Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Sinovac Biotech Ltd

SVA ✗ NOT COMPLIANT ☆ Track — members

Nasdaq · Healthcare · Pharmaceuticals ·

USA Small Cap Analyst: N/A

Last Close

$6.47

Market Cap $639.90M · Vol 2.46K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$639.90M

Small Cap

Div Yield

N/A

Dividend with no set frequency

EPS Growth

N/A

YoY

RSI (14)

50.00

Momentum

Beta

N/A

vs Market

52W High

N/A

1.52% below

52W Low

N/A

0.15% above

Volume

2.46K

Avg 0

P/B

N/A

Price-to-book

ROE

N/A

Return on equity

Free Float

12.69%

Public shares

Shariah Compliance8 STANDARDS

✗ Sinovac Biotech Ltd (SVA) stock is currently not Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See which standards it fails, the exact ratios behind the verdict, and halal alternatives. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does SVA pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

N/A

YTD

N/A

+0.00%

N/A

Financials & Valuation

TTM · Annual

Total Revenue	$386.01M
Net Income	$-198,836,000.00
Revenue Growth (YoY)	+6.54%
Gross Margin	67.87%
Operating Margin	-74.42%
Net Profit Margin	-51.51%
ROE	N/A
ROA · ROIC	-2.51% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	N/A
P/B	N/A
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	71.86M

Technical Indicators

50-Day SMA	$6.47
200-Day SMA	$6.47
RSI (14)	50.00
Beta	N/A
52-Week High	N/A
52-Week Low	N/A

Volume Today	2.46K
Avg Daily Volume (30D)	0
Relative Volume	N/Ax
Volatility (10D)	0.00
Volatility (30D)	0.00
Free Float	12.69%

Analyst Consensus

N/A

Current Price $6.47

Mean Target N/A

52W LowN/A 52W HighN/A

Current

Target

N/A N/A

Current Analyst target

· 0 analysts

Identifiers

ExchangeNasdaq

FIGIBBG001SGZBN3

ISINAGP8696W1045

CountryChina

Sub-IndustryBiopharmaceuticals

Earnings DateN/A

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

REGN Regeneron Pharmaceuticals Inc -0.31% 207940.KS Samsung Biologics Co Ltd -1.02% UCB.BR Ucb SA -3.10% CSL.AX CSL Ltd -0.74% BIIB Biogen Inc -0.39%

Company Profile

Sinovac Biotech Ltd (Sinovac) is a holding company. The Company is a biopharmaceutical company that focuses on the research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases, including hepatitis A, hepatitis B, hand foot and mouth disease (HFMD), seasonal influenza, Haemagglutinase5 Neuraminidase1 (H5N1) and Influenza A (H1N1) pandemic influenza, coronavirus, pneumococcus, poliomyelitis, varicella and mumps. The Company's pipeline consists of vaccine candidates in the clinical and pre-clinical development Phases in China. The Company is engaged in the sales, marketing, manufacturing and development of vaccines for infectious disease. The Company develops various products, including Healive, Bilive, Anflu, Panflu Whole Viron Pandemic Influenza Vaccine, Split Viron Pandemic Influenza Vaccine, Panflu.1, Mumps Vaccine, Enterovirus 71 (EV71) Vaccine, Pneumococcal Polysaccharide Vaccine, Pneumococcal Conjugate Vaccine.